Growth Metrics

Omeros (OMER) Finished Goods (2014 - 2021)

Omeros recorded quarterly Finished Goods of $184000.0 in Q3 2021, down 52.45% quarter-over-quarter from $387000.0 in Q2 2021, and down 72.37% year-over-year from $666000.0 in Q3 2020.

Omeros' Finished Goods history runs 8 years deep, the most recent figure standing at $184000.0 for Q3 2021.

  • In Q3 2021, Finished Goods fell 72.37% year-over-year to $184000.0; the TTM figure through Sep 2021 stood at $184000.0 (down 72.37% YoY), while the FY2020 annual figure was $784000.0, up 9.19% from the prior year.
  • Finished Goods came in at $184000.0 for Q3 2021 at Omeros, down from $387000.0 in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $784000.0 in Q4 2020 to a low of $5000.0 in Q4 2018.
  • A 5-year average of $509076.9 and a median of $586000.0 in 2019 frame the typical range for Finished Goods.
  • Across the five-year window, Finished Goods slumped 98.61% in 2018 and jumped 14260.0% in 2019, its largest moves.
  • Omeros' Finished Goods stood at $360000.0 in 2017, then plunged by 98.61% to $5000.0 in 2018, then surged by 14260.0% to $718000.0 in 2019, then rose by 9.19% to $784000.0 in 2020, then slumped by 76.53% to $184000.0 in 2021.
  • According to Business Quant data, Finished Goods over the past three periods registered $184000.0, $387000.0, and $544000.0 for Q3 2021, Q2 2021, and Q1 2021 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2021 184,000.00
Jun 30, 2021 387,000.00
Mar 31, 2021 544,000.00
Dec 31, 2020 784,000.00
Sep 30, 2020 666,000.00
Jun 30, 2020 606,000.00
Mar 31, 2020 726,000.00
Dec 31, 2019 718,000.00
Sep 30, 2019 751,000.00
Jun 30, 2019 586,000.00
Mar 31, 2019 301,000.00
Dec 31, 2018 5,000.00
Dec 31, 2017 360,000.00
Dec 31, 2016 173,000.00
Dec 31, 2015 221,000.00
Dec 31, 2014 568,000.00